Friendswood, Texas — According to state and local development sources, Castle Biosciences plans to invest $25,970,575.00 to build out 86,151 square feet of new space in Friendswood. The company plans to occupy the new space at 1500 W Parkwood Ave in Friendswood, on or about July 1, 2025. According to the company website Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company focused on transforming disease management by keeping people first the patients who benefit from the information that our advanced diagnostic tests provide, the clinicians who use our tests to guide disease management decisions, our talented and valued employees, and our investors. Our innovative portfolio of commercial and pipeline tests targets unmet clinical need along the patient care continuum. We currently market six proprietary tests designed to answer clinical questions and address treatment plan challenges facing physicians in dermatologic cancers, uveal melanoma, Barretts esophagus, and mental health.

To learn more about Castle Biosciences, visit http://castlebiosciences.com/

Company Contact:
Derek Maetzold, Chief Executive Officer
dmaetzold@castlebiosciences.com
https://www.linkedin.com/in/derek-maetzold-5070855/
866-788-9007

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.